The mechanical properties of tissue matrix are crucial for maintaining cell health and function. With aging, tissue matrix loses its mechanical integrity and exhibits altered biophysical properties, ...

Geroscience frames age-related diseases as being driven by ‘gerogenes,’ opening a path to gerotherapies that target ageing ...

Glioblastoma multiforme (GBM) is the most aggressive and common type of brain cancer in adults, with a dismal prognosis despite current treatments. Previous work found that neurodevelopmental pathways ...

CRISPR mouse models show EML4-ALK fusion variants alter drug response, suggesting a need for variant-specific treatment.

KRAS is one of the most frequently mutated oncogenes in human cancers. Once thought “undruggable,” recent scientific advances ...

The BRAF Tests market presents significant opportunities in melanoma treatment, driven by technological advancements and regulatory insights. Key opportunities lie in market segmentation, emerging ...

Targeted therapies have changed non-small cell lung cancer care, but new side effects, like weight gain, are emerging, says Dr. Lorenzo Belluomini.

Illumina Inc. (NASDAQ: ILMN) will partner with multiple global pharmaceutical companies to develop companion diagnostics (CDx ...

Human papillomavirus (HPV) is the primary cause of virus-associated cancers, especially cervical and head and neck cancers. A ...

The Subject Expert Committee (SEC) functioning under the Central Drugs Standard Control Organisation (CDSCO), has opined ...

Gene therapy offers the possibility of addressing cancer at its molecular roots by targeting disease-causing genes rather than relying solely on surgery, chemotherapy, or radiotherapy.